Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumors × litronesib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 3 Stomach Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Gemcitabine 9 Paclitaxel 7 Carboplatin 7 atezolizumab 5 Sunitinib 5 navitoclax 4 Topotecan 4 Irinotecan 4 Docetaxel 4 Bevacizumab 4 pazopanib 3 liposomal doxorubicin 3 Nivolumab 3 Erlotinib Hydrochloride 3 zolbetuximab 2 temsirolimus 2 selicrelumab 2 plocabulin 2 envafolimab 2 darinaparsin 2 cobimetinib 2 brigimadlin 2 Tablets 2 Sorafenib 2 Rifampin 2 Panitumumab 2 NVP-BKM120 2 Lapatinib 2 Ketoconazole 2 Everolimus 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01358019 2013-01-28

2523355-001

Kyowa Kirin Co., Ltd.

Phase 1 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡